Outlook Therapeutics Cash Flow Statement (2015-2026) | OTLK

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Cash Flow Statement	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026
Operating Activities
Net Income (Quarter)	-12.20M	-13.40M	-13.15M	-19.70M	-17.54M	-14.35M	-15.69M	-6.65M	-20.68M	-12.99M	-10.32M	-114.29M	44.41M	5.69M	-21.61M	-46.36M	-20.15M	-13.29M	-13.48M	-4.45M
Depreciation and Depletion (Quarter)	0.04M	0.04M	0.04M	0.04M	0.04M	0.04M
Share-based Compensation (Quarter)	1.20M	1.40M	1.20M	3.76M	1.37M	1.38M	1.39M	1.38M	1.38M	1.39M	1.27M	1.31M	1.40M	1.41M	3.67M	1.70M	1.67M	1.78M	0.88M	0.76M
Gains from Sales and Divestitures (Quarter)	1.81M		1.81M
Gains from Investment Securities (Quarter)		0.43M	-0.25M	1.00M	-0.23M	-0.01M	-0.03M	22.06M	1.90M	0.25M	0.53M	0.67M	0.00M	0.00M	-40.27M	1.20M	2.00M	0.06M	2.79M	0.48M
Asset Writedowns and Impairment (Quarter)
Non-cash Items (Quarter)	4.99M	11.04M	12.10M	13.43M	2.77M	11.02M	3.30M	10.11M	10.16M	13.57M	7.99M	4.22M	0.95M	0.05M	6.50M	4.80M	0.00M	2.02M	1.49M	3.27M
Cash from Operations (Quarter)	-20.19M	-8.99M	-10.99M	-14.33M	-21.10M	-10.25M	-8.90M	-8.11M	-13.22M	-12.74M	-13.03M	-19.27M	-19.51M	-16.98M	-10.97M	-16.58M	-11.90M	-12.38M	-14.94M	-7.83M
Depreciation, Depletion & Amortization
Amortization of Deferred Charges (Quarter)	0.25M	0.25M	0.34M	0.42M	0.44M	0.46M	2.53M
Depreciation & Amortization (CF) (Quarter)	0.05M	0.05M	0.05M	0.05M	0.05M	0.05M	0.01M	0.01M	0.01M	0.01M	0.03M	0.03M	0.03M	0.03M	0.03M	0.03M	0.03M	0.03M	0.03M	0.03M
Change in Working Capital
Change in Receivables (Quarter)																		-0.26M	-1.38M	2.61M
Change in Inventory (Quarter)															3.11M	0.50M	0.52M	-0.79M	0.12M	-0.11M
Change in Account Payables (Quarter)	-3.49M	-0.39M	0.17M	1.79M	-1.68M	1.01M	0.68M	-0.55M	1.20M	1.76M	-3.09M	0.27M	1.69M	2.53M	4.22M	-4.63M	2.04M	0.03M	-2.87M	5.71M
Change in Accured Expenses (Quarter)	-1.00M	-1.77M	1.04M	-0.21M	-0.52M	-0.15M	5.01M	-2.22M	2.06M	-5.56M	1.34M	-1.00M	-0.41M	0.56M	0.15M	-0.99M	2.20M	0.35M	-0.30M	4.39M
Change in Taxes (Quarter)
Other Working Capital Changes (Quarter)	-1.46M	1.87M	-0.01M	1.10M	-1.12M	-0.01M	-0.79M	0.77M	-0.80M	-1.79M	2.45M	0.01M	0.01M	4.90M	-0.01M	0.03M	0.03M	-1.84M	-0.01M	0.01M
Investing Activities
Capital Expenditures (Quarter)
Cash from Investing Activities (Quarter)
Financing Activities
Other financing activities (Quarter)			0.60M				0.57M	0.25M
Cash from Financing Activities (Quarter)	2.72M	3.78M	66.66M	2.61M	-11.30M	1.63M	43.85M	-0.60M	3.30M	2.42M	-0.00M	56.14M	4.31M	-0.11M	1.74M	18.44M	13.25M	11.56M	15.53M	6.90M
Additional items
Exchange Rate Effect (Quarter)
Change in Cash (Quarter)	-17.48M	-5.21M	55.67M	-11.73M	-32.40M	-8.62M	34.94M	-8.71M	-9.92M	-10.32M	-13.04M	36.87M	-15.20M	-17.10M	-9.22M	1.85M	1.34M	-0.82M	0.59M	-0.93M
Free Cash Flow (Quarter)	-20.19M	-8.99M	-10.99M	-14.33M	-21.10M	-10.25M	-8.90M	-8.11M	-13.22M	-12.74M	-13.03M	-19.27M	-19.51M	-16.98M	-10.97M	-16.58M	-11.90M	-12.38M	-14.94M	-7.83M
Net Cash Flow (Quarter)	-17.48M	-5.21M	55.67M	-11.73M	-32.40M	-8.62M	34.94M	-8.71M	-9.92M	-10.32M	-13.04M	36.87M	-15.20M	-17.10M	-9.22M	1.85M	1.34M	-0.82M	0.59M	-0.93M

Research Tools

Developers

Outlook Therapeutics Cash Flow Statement (2015-2026) | OTLK

Research Tools

Developers

Outlook Therapeutics Cash Flow Statement (2015-2026) | OTLK

Create an account

Sign In

Reset Password